July 16, 2014 / 4:08 AM / 6 years ago

Sun Pharma acquires U.S.-based Pharmalucence

An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014. REUTERS/Danish Siddiqui/Files

MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd (SUN.NS), India’s third-largest generic drugmaker by sales, said on Wednesday it had acquired U.S.-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.

Financial details of the deal were not disclosed.

Reporting by Sumeet Chatterjee; Editing by Prateek Chatterjee

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below